Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HZ.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HZ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HZ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HZ.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.69ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.69NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.98ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.98ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.98ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.98NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.71ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.71NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HT.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HT.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.90ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-524.276France
XBB.1.5.90ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.90ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
XBB.1.5.90NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16988.9US
FL.18.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.18.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.18.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used